Jane Street’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-41,054
| Closed | -$7.07M | – | 11221 |
|
|
2021
Q3 | $7.07M | Buy |
41,054
+32,029
| +355% | +$4.19M | ﹤0.01% | 2260 |
|
|
2021
Q2 | $1.13M | Buy |
9,025
+3,959
| +78% | +$499K | ﹤0.01% | 5568 |
|
|
2021
Q1 | $687K | Sell |
5,066
-9,690
| -66% | -$1.25M | ﹤0.01% | 6205 |
|
|
2020
Q4 | $1.89M | Sell |
14,756
-25,517
| -63% | -$2.99M | ﹤0.01% | 3588 |
|
|
2020
Q3 | $4.53M | Sell |
40,273
-80,270
| -67% | -$7.99M | ﹤0.01% | 1953 |
|
|
2020
Q2 | $11.5M | Buy |
120,543
+92,663
| +332% | +$8.93M | 0.01% | 1095 |
|
|
2020
Q1 | $2.51M | Buy |
+27,880
| New | +$2.17M | ﹤0.01% | 1790 |
|
|
2019
Q4 | – | Sell |
-11,286
| Closed | -$446K | – | 6024 |
|
|
2019
Q3 | $446K | Buy |
11,286
+3,238
| +40% | +$140K | ﹤0.01% | 3682 |
|
|
2019
Q2 | $331K | Buy |
+8,048
| New | +$333K | ﹤0.01% | 4072 |
|
|
2018
Q2 | – | Sell |
-6,404
| Closed | -$250K | – | 5853 |
|
|
2018
Q1 | $250K | Sell |
6,404
-4,115
| -39% | -$175K | ﹤0.01% | 4224 |
|
|
2017
Q4 | $446K | Sell |
10,519
-28,618
| -73% | -$1.07M | ﹤0.01% | 3317 |
|
|
2017
Q3 | $1.46M | Buy |
+39,137
| New | +$1.36M | ﹤0.01% | 1901 |
|
|
2016
Q1 | – | Sell |
-4,557
| Closed | -$222K | – | 4818 |
|
|
2015
Q4 | $222K | Buy |
+4,557
| New | +$164K | ﹤0.01% | 3463 |
|
|
2014
Q3 | – | Sell |
-14,621
| Closed | -$497K | – | 3233 |
|
|
2014
Q2 | $497K | Buy |
+14,621
| New | +$489K | 0.01% | 1412 |
|
Jane Street's XLRN Position: Q4 2021 in Review
Jane Street sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 41,054 shares — an estimated $7.07M sold.
Jane Street first reported a position in XLRN in Q2 2014 and held it in 14 quarters. The position peaked at $11.5M in Q2 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.
- Jane Street reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
- Jane Street sold 41,054 Acceleron Pharma shares in Q4 2021, an estimated $7.07M.
- Jane Street first reported a position in Acceleron Pharma in Q2 2014 and held it in 14 quarters.
- Jane Street's Acceleron Pharma position peaked at $11.5M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.
Based on Jane Street's 13F filing for Q4 2021, filed 15 Feb 2022.